WLFI, the governance token of Trump family-backed cryptocurrency platform World Liberty Financial, fell sharply on Sunday, ending a week plagued by crashes and controversy. WLFI plunged over 10% over ...

A key crude oil distillation unit has been destroyed at the Ilsky oil refinery in Russia’s Krasnodar Krai by Ukrainian Special Operations Forces (SOF), together with the Russian resistance movement ...

In today’s economy, traditional ownership is increasingly inaccessible and misaligned with the real estate landscape. Ongoing issues with low inventory, high home prices, elevated mortgage rates, and ...

For years, the PR strategy at Misfits Market, the “ugly” produce subscription service, was largely reactive, pitching announcements to reporters ad hoc or chasing the occasional media placement. But ...

This Twin Cities company's experience with a fractional executive has been so positive, leaders are considering expanding the approach to other C-suite positions ...

Christian Howell, CEO of Cognito Therapeutics, sits down with Nasdaq’s Kristina Ayanian to discuss the company’s breakthrough approach to treating Alzheimer’s using light and sound stimulation. From ...

If you’re leading a growing organization but can’t justify the cost of full-time executives, there’s another way. Imagine you’re leading a small organization, but you’re struggling to recruit and ...

Kelly Chartre launched Visionary Balance, a fractional chief marketing officer service, focusing on travel and leisure businesses. She left her role as VP of Marketing at Fox World Travel to fully ...

The largest Cogito v2 671B MoE model is amongst the strongest open models in the world. It matches/exceeds the performance of the latest DeepSeek v3 and DeepSeek R1 models both, and approaches closed ...

On Tuesday, Cathie Wood-led Ark Invest executed significant trades, focusing on Bitmine Immersion Technologies Inc. (NYSE:BMNR) and Block Inc. (NYSE:XYZ). These trades reflect Ark’s strategic ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a clinical-stage neurotechnology company pioneering neuromodulation-based treatments for neurodegenerative diseases, announced five new poster ...